Sanofi, Re­gen­eron etch out an­oth­er PhI­II vic­to­ry for Dupix­ent, eas­ing se­vere itch and clear­ing le­sions

Sanofi and Re­gen­eron can boast of an­oth­er in­flam­ma­to­ry dis­ease where Dupix­ent has proven ef­fec­tive.

The best-sell­ing drug, which tar­gets both IL-4 and IL-13, has de­liv­ered …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER